neurogenetics

, Volume 12, Issue 3, pp 169–173 | Cite as

Call for participation in the neurogenetics consortium within the Human Variome Project

  • Andrea Haworth
  • Lars Bertram
  • Paola Carrera
  • Joanna L. Elson
  • Corey D. Braastad
  • Diane W. Cox
  • Marc Cruts
  • Johann T. den Dunnen
  • Matthew J. Farrer
  • John K. Fink
  • Sherifa A. Hamed
  • Henry Houlden
  • Dennis R. Johnson
  • Karen Nuytemans
  • Francesc Palau
  • Dipa L. Raja Rayan
  • Peter N. Robinson
  • Antonio Salas
  • Birgitt Schüle
  • Mary G. Sweeney
  • Michael O. Woods
  • Jorge Amigo
  • Richard G. H. Cotton
  • Maria-Jesus Sobrido
NEUROGENETICS NEWS

Abstract

The rate of DNA variation discovery has accelerated the need to collate, store and interpret the data in a standardised coherent way and is becoming a critical step in maximising the impact of discovery on the understanding and treatment of human disease. This particularly applies to the field of neurology as neurological function is impaired in many human disorders. Furthermore, the field of neurogenetics has been proven to show remarkably complex genotype-to-phenotype relationships. To facilitate the collection of DNA sequence variation pertaining to neurogenetic disorders, we have initiated the “Neurogenetics Consortium” under the umbrella of the Human Variome Project. The Consortium’s founding group consisted of basic researchers, clinicians, informaticians and database creators. This report outlines the strategic aims established at the preliminary meetings of the Neurogenetics Consortium and calls for the involvement of the wider neurogenetic community in enabling the development of this important resource.

Keywords

Human Variome project Neurogenetics consortium Database Genetic variation Standardisation Phenotype 

References

  1. 1.
    Cotton RG, Appelbe W, Auerbach AD, Becker K, Bodmer W, Boone DJ, Boulyjenkov V, Brahmachari S, Brody L, Brookes A, Brown AF, Byers P, Cantu JM, Cassiman JJ, Claustres M, Concannon P, Cotton RG, den Dunnen JT, Flicek P, Gibbs R, Hall J, Hasler J, Katz M, Kwok PY, Laradi S, Lindblom A, Maglott D, Marsh S, Masimirembwa CM, Minoshima S, de Ramirez HZ, Scriver CR, Sherry S, Shimizu N, Shimizu N, Stein L, Tadmouri GO, Taylor G, Watson M (2007) Recommendations of the 2006 Human Variome Project Meeting. Nat Genet 39:433–436PubMedCrossRefGoogle Scholar
  2. 2.
    Kaput J, Cotton RG, Hardman L, Watson M, Al Aqeel AI, Al-Aama JY, Al-Mulla F, Alonso S, Aretz S, Auerbach AD, Bapat B, Bernstein IT, Bhak J, Bleoo SL, Blöcker H, Brenner SE, Burn J, Bustamante M, Calzone R, Cambon-Thomsen A, Cargill M, Carrera P, Cavedon L, Cho YS, Chung YJ, Claustres M, Cutting G, Dalgleish R, den Dunnen JT, Díaz C, Dobrowolski S, dos Santos MR, Ekong R, Flanagan SB, Flicek P, Furukawa Y, Genuardi M, Ghang H, Golubenko MV, Greenblatt MS, Hamosh A, Hancock JM, Hardison R, Harrison TM, Hoffmann R, Horaitis R, Howard HJ, Barash CI, Izagirre N, Jung J, Kojima T, Laradi S, Lee YS, Lee JY, Gil-da-Silva-Lopes VL, Macrae FA, Maglott D, Marafie MJ, Marsh SG, Matsubara Y, Messiaen LM, Möslein G, Netea MG, Norton ML, Oefner PJ, Oetting WS, O’Leary JC, de Ramirez AM, Paalman MH, Parboosingh J, Patrinos GP, Perozzi G, Phillips IR, Povey S, Prasad S, Qi M, Quin DJ, Ramesar RS, Richards CS, Savige J, Scheible DG, Scott RJ, Seminara D, Shephard EA, Sijmons RH, Smith TD, Sobrido MJ, Tanaka T, Tavtigian SV, Taylor GR, Teague J, Töpel T, Ullman-Cullere M, Utsunomiya J, van Kranen HJ, Vihinen M, Webb E, Weber TK, Yeager M, Yeom YI, Yim SH, Yoo HS, Contributors to the Human Variome Project Planning Meeting (2009) Planning the Human Variome Project: the Spain Report. Hum Mutat 30:496–510PubMedCrossRefGoogle Scholar
  3. 3.
    Cotton RG, Al Aqeel AI, Al-Mulla F, Carrera P, Claustres M, Ekong R, Hyland VJ, Macrae FA, Marafie MJ, Paalman MH, Patrinos GP, Qi M, Ramesar RS, Scott RJ, Sijmons RH, Sobrido MJ, Vihinen M, members of the Human Variome Project (2010) Data Collection from Clinics, Data Collection from Laboratories and Publication, Credit and Incentives Working Groups. Capturing all disease causing mutations for clinical and research use: towards an effortless system for the Human Variome Project. Genet Med 11:843–849CrossRefGoogle Scholar
  4. 4.
    Cotton RG, Auerbach AD, Axton M, Barash CI, Berkovic SF, Brookes AJ, Burn J, Cutting G, den Dunnen JT, Flicek P, Freimer N, Greenblatt MS, Howard HJ, Katz M, Macrae FA, Maglott D, Möslein G, Povey S, Ramesar RS, Richards CS, Seminara D, Smith TD, Sobrido MJ, Solbakk JH, Tanzi RE, Tavtigian SV, Taylor GR, Utsunomiya J, Watson M (2008) GENETICS. The Human Variome Project. Science 322:861–862PubMedCrossRefGoogle Scholar
  5. 5.
    Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (2010) Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 31:763–780PubMedCrossRefGoogle Scholar
  6. 6.
    Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17–23PubMedCrossRefGoogle Scholar
  7. 7.
    Lill CM, McQueen MB, Roehr JT, Schjeide BMM, Zauft U, Bagade S, Zipp F, Bertram L. Schjeide BMM, McQueen MB, Bertram L (2010) The MSGene Database Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Multiple Sclerosis Slide presentation at the 62nd Annual Meeting of the American Academy of Neurology, Toronto, Canada [S30.003]Google Scholar
  8. 8.
    Tuffery-Giraud S, Béroud C, Leturcq F, Yaou RB, Hamroun D, Michel-Calemard L, Moizard MP, Bernard R, Cossée M, Boisseau P, Blayau M, Creveaux I, Guiochon-Mantel A, de Martinville B, Philippe C, Monnier N, Bieth E, Khau Van Kien P, Desmet FO, Humbertclaude V, Kaplan JC, Chelly J, Claustres M (2009) Genotype–phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat 30:934–945PubMedCrossRefGoogle Scholar
  9. 9.
    Robinson PN, Köhler S, Bauer S, Seelow D, Horn D, Mundlos S (2008) TheHuman Phenotype Ontology: a tool for annotating and analyzing humanhereditary disease. Am J Hum Genet 83:610–615PubMedCrossRefGoogle Scholar
  10. 10.
    Salas A, Carracedo A, Macaulay V, Richards M, Bandelt HJ (2005) A practical guide to mitochondrial DNA error prevention in clinical, forensic, and population genetics. Biochem Biophys Res Commun 335:891–899PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Andrea Haworth
    • 1
  • Lars Bertram
    • 2
  • Paola Carrera
    • 3
  • Joanna L. Elson
    • 4
  • Corey D. Braastad
    • 5
  • Diane W. Cox
    • 6
  • Marc Cruts
    • 7
  • Johann T. den Dunnen
    • 8
  • Matthew J. Farrer
    • 9
  • John K. Fink
    • 10
  • Sherifa A. Hamed
    • 11
  • Henry Houlden
    • 12
  • Dennis R. Johnson
    • 13
  • Karen Nuytemans
    • 7
  • Francesc Palau
    • 14
  • Dipa L. Raja Rayan
    • 12
  • Peter N. Robinson
    • 15
  • Antonio Salas
    • 16
  • Birgitt Schüle
    • 17
  • Mary G. Sweeney
    • 1
  • Michael O. Woods
    • 18
  • Jorge Amigo
    • 19
  • Richard G. H. Cotton
    • 20
  • Maria-Jesus Sobrido
    • 21
    • 22
  1. 1.Neurogenetics Unit, Department of Molecular NeurosciencesNational Hospital of Neurology and NeurosurgeryLondonUK
  2. 2.Neuropsychiatric Genetic Vertebrate GenomicsMax-Planck Institute for Molecular GeneticsBerlinGermany
  3. 3.San Raffaele Scientific Institute, Center for Translational Genomics and Bioinformatics, Unit of Genomics for Human Disease Diagnosis and LaborafMilanItaly
  4. 4.Mitochondrial Research Group, Institute for Ageing and HealthNewcastle UniversityNewcastle upon TyneUK
  5. 5.Athena DiagnosticsWorcesterUSA
  6. 6.Department of Medical GeneticsUniversity of AlbertaEdmontonCanada
  7. 7.Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, University of AntwerpAntwerpBelgium
  8. 8.Human and Clinical GeneticsLeiden University Medical CenterLeidenthe Netherlands
  9. 9.Centre for Applied Neurogenetics, Brain Research CentreUniversity of British ColumbiaVancouverCanada
  10. 10.Department of Neurology and Geriatric Research Education and Clinical Center, Ann Arbor Veterans Affairs Medical CenterUniversity of MichiganAnn ArborUSA
  11. 11.Department of Neurology and PsychiatryAssiut University HospitalAssiutEgypt
  12. 12.MRC Centre for Neuromuscular DiseasesUCL Institute of NeurologyLondonUK
  13. 13.Evidence Based Healthcare Consulting, LCCCheshireUSA
  14. 14.Institute of Biomedicine of Valencia, CSIC and Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos IIIValenciaSpain
  15. 15.Institute for Medical Genetics and Human GeneticsCharité Universitätsmedizin BerlinBerlinGermany
  16. 16.Genetics Unit, Department of Pathology and Forensic Sciences, Institute of Legal Medicine, School of MedicineUniversity of Santiago de CompostelaSantiago de CompostelaSpain
  17. 17.The Parkinson’s Institute and Clinical CenterSunnyvaleUSA
  18. 18.Discipline of GeneticsMemorial University of NewfoundlandSt. John’sCanada
  19. 19.Genomic Medicine GroupUniversity of Santiago de Compostela, Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos IIISantiago de CompostelaSpain
  20. 20.Genomic Disorders Research Centre and Department of Medicine (St. Vincent’s)University of MelbourneMelbourneAustralia
  21. 21.Fundación Pública Galega de Medicina XenómicaSantiago de CompostelaSpain
  22. 22.Center for Biomedical Network Research on Rare Diseases (CIBERER)Institute of Health Carlos IIISantiago de CompostelaSpain

Personalised recommendations